Effect of the 4′-substituted phenylalanine moiety of sansalvamide A peptide on antitumor activity

MedChemComm

Volumn 5, Issue 4, 2014, Pages 463-467

  Liu, Shouxin ^a   Yang, Yihua ^a   Zhao, Cuiran ^a   Huang, Jing ^a   Han, Chunyu ^a   Han, Jianrong ^a  

^a HEBEI UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BROMIDE; CHLORIDE; FLUORIDE; IODIDE; PHENYLALANINE; SANSALVAMIDE A; UNCLASSIFIED DRUG;

ALLYLATION; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CYTOTOXICITY; DRUG EFFECT; DRUG SCREENING; DRUG STRUCTURE; GROWTH INHIBITION; HUMAN; MELANOMA; METHYLATION; PANCREAS CANCER; PRIORITY JOURNAL; PROSTATE CANCER; STRUCTURE ACTIVITY RELATION;

EID: 84897012174     PISSN: 20402503     EISSN: 20402511     Source Type: Journal    
DOI: 10.1039/c3md00294b     Document Type: Article

References (23)

1. G. N. Belofsky P. R. Jensen W. Fenical Sansalvamide: A new cytotoxic cyclic depsipeptide produced by a marine fungus of the genus Fusarium Tetrahedron Lett. 1999 40 2913 2916
2. M. B. Ujiki B. Milam X.-Z. Ding A. B. Roginsky M. R. Salabat M. S. Talamonti R. H. Bell W. Gu R. B. Silverman T. E. Adrian A novel peptide sansalvamide analogue inhibits pancreatic cancer cell growth through G0/G1 cell-cycle arrest Biochem. Biophys. Res. Commun. 2006 340 1224 1228
3. J. B. Kunicki M. N. Petersen L. D. Alexander V. C. Ardi J. R. McConnell S. R. McAlpine Synthesis and evaluation of biotinylated sansalvamide A analogs and their modulation of Hsp90 Bioorg. Med. Chem. Lett. 2011 21 14716 14719
4. R. B. Silverman, S. Liu, W. Gu, T. Adrian and G. S. Wilmette, Cyclic peptide antitumor agents, US Pat., 7709443, 2010
5. R. B. Silverman, S. Liu, W. Gu, T. Adrian and G. S. Wilmette, Cyclic peptide antitumor agents, US Pat., 8058244, 2011
6. K. Otrubova K. L. McGuire S. R. McAlpine Scaffold targeting drug-resistant colon cancers J. Med. Chem. 2007 50 1999 2002
7. W. Gu S. Liu R. B. Silverman Solid-phase, Pd-catalyzed silicon-aryl carbon bond formation. Synthesis of sansalvamide A peptide Org. Lett. 2002 4 4171 4174
8. S. Liu Y. Geng X. Tian X. Zhen J. Han Total synthesis of N-methylsansalvamide A Chin. Chem. Lett. 2006 17 761 764
9. S. Liu X. Feng Y. Geng J. Yao J. Li Novel solid-phase synthetic method of sansalvamide A Chin. J. Org. Chem. 2005 25 604 607
10. S. Liu W. Gu D. Lo X. Ding M. Ujiki T. E. Adrian G. A. Soff R. B. Silverman N-Methylsansalvamide A peptide analogues. Potent new antitumor agents J. Med. Chem. 2005 48 3630 3638
11. T. J. Styers A. Kekec R. Rodriguez J. D. Brown J. Cajica P. Pan E. Parry C. L. Carroll I. Medina R. Corral S. Lapera K. Otrubova C. Pan K. L. McGuireb S. R. McAlpine Synthesis of sansalvamide A derivatives and their cytotoxicity in the MSS colon cancer cell line HT-29 Bioorg. Med. Chem. 2006 14 5625 5631
12. R. A. Rodriguez P. C. Pan S. Ravula S. Lapera E. K. Singh T. J. Styers J. D. Brown J. Cajica E. Parry K. Otrubova S. R. McAlpine Synthesis of second-generation sansalvamide A derivatives: Novel templates as potential antitumor agents J. Org. Chem. 2007 72 1980 2002
13. P. Pan K. L. McGuire S. R. McAlpine Identification of sansalvamide A analog potent against pancreatic cancer cell lines Bioorg. Med. Chem. Lett. 2007 17 5072 5077
14. K. Otrubova G. Lushington D. V. Velde K. L. McGuire S. R. McAlpine Comprehensive study of sansalvamide A derivatives and their structure-activity relationships against drug-resistant colon cancer cell lines J. Med. Chem. 2008 51 530 544
15. R. A. Rodriguez P. Pan R. C. Vasko C. Pan W. S. Disman S. R. McAlpine Structure-activity of sansalvamide A derivatives and their apoptotic activity in the pancreatic cancer cell line PL-45 J. Mex. Chem. Soc. 2008 52 201 211
16. P. Pan R. C. Vasko S. A. Lapera V. A. Johnson R. P. Sellers C. Lin C. Pan M. R. Davis V. C. Ardi S. R. McAlpine A comprehensive study of sansalvamide A derivatives: The structure-activity relationships of 78 derivatives in two pancreatic cancer cell lines Bioorg. Med. Chem. 2009 17 5806 5825
17. R. P. Sellers L. D. Alexander V. A. Johnson C. Lin J. Savage R. Corral J. Moss T. S. Slugocki E. K. Singh M. R. Davis S. Ravula J. E. Spicer J. L. Oelrich A. Thornquist C. Pan S. R. McAlpine Design and synthesis of Hsp90 inhibitors: Exploring the SAR of sansalvamide A derivatives Bioorg. Med. Chem. 2010 18 6822 6856
18. M. R. Davis E. K. Singh H. Wahyudi L. D. Alexander J. B. Kunicki L. A. Nazarova K. A. Fairweather A. M. Giltrap K. A. Jolliffe S. R. McAlpine Synthesis of sansalvamide A peptidomimetics: triazole, oxazole, thiazole, and pseudoproline containing compounds Tetrahedron 2012 68 1029 1051
19. I. lbert A. L. Mercedes F. Albericio Amino Acid-Protecting Groups Chem. Rev. 2009 109 2455 2504
20. F. P. J. T. Rutjes J. J. N. Veerman W. J. N. Meester H. Hiemstra H. E. Schoemaker Synthesis of enantiopure functionalized pipecolic acids via amino acid derived N-acyliminium ions Eur. J. Org. Chem. 1999 1127 1135
21. F. Yokokawa A. Inaizumi T. Shioiri Synthetic studies of the cyclic depsipeptides bearing the 3-amino-6-hydroxy-2-piperidone (Ahp) unit. Total synthesis of the proposed structure of micropeptin T-20 Tetrahedron 2005 61 1459 1480
22. S. Chandrasekhar T. Ramachandar M. Venkat Reddy An efficient synthesis of (-)-deacetylanisomycin starting from d-tyrosine Synthesis 2002 1867 1870
23. N. Shibata J. E. Baldwin A. Jacobs M. E. Wood Electrophilic sulfenylation in a stereocontrolled synthesis of protected (2R,3R)-3-mercaptoaspartic acid from l-aspartic acid Tetrahedron 1996 52 12839 12852